Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials

Cambridge - Congenica, a leading digital health company specialising in the provision of software and solutions for genomic data analysis and interpretation, and myTomorrows, a global platform facilitating access to pre-approval treatments and clinical trials, have partnered to expedite access to precision oncology for cancer patients worldwide. The partnership between Congenica and myTomorrows will open [...]

MGI’s Innovative Technologies Is Enabling Sequencing of First Plant Species in The African BioGenome Project

Cape Town, South Africa – MGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project's first plant species based on MGI's DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology. An affiliated [...]

MolGen appoints Hayden Jeffreys as Global Vice President of Sales & Marketing

Veenendaal, the Netherlands – MolGen, a global solutions provider of innovative DNA/RNA extraction and lab automation, has appointed Hayden Jeffreys as Global Vice President of Sales & Marketing. Mr Jeffreys has held a variety of C-suite roles from his most recent position as COO of AIM listed Yourgene Health plc and President of Yourgene Health Inc. [...]

WLC 6/A2/1 – a New Balance in RADWAG’s Offer

Readability [d] 1 g and maximum capacity [Max] 6 kg – this is what the new WLC 6/A2/1 precision balance from RADWAG features. Thanks to high accuracy on the one hand and an internal battery and stainless steel weighing pan on the other, the WLC 6/A2/1 balance can be used both in demanding laboratory environments and in [...]

MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

CHEONAN, South Korea -- MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology. The MOU is expected to reach collaborations in localizing MGI's manufacturing capability in selected genetic sequencers and reagents in South Korea via [...]

BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization

As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products DURHAM, N.C. -- BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced [...]

Curiox Biosystems to Advance Next-Generation Cancer Cell Therapies Through Collaboration with Leading Cancer Researcher

BOSTON -- Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies. https://www.youtube.com/watch?v=2AF8nyanzc4 The collaboration [...]

Willkie Advises Qualium Investissement and Lauxera Capital Partners in Acquisition of VERDOT

On September 13, Willkie clients Qualium Investissement and Lauxera Capital Partners announced their acquisition of a majority stake in VERDOT, a leading provider of chromatographic purification solutions. Qualium Investissement and Lauxera Capital Partners acquired a majority stake in VERDOT through an investment of over €65 million, alongside the company’s management team and existing shareholders Capital [...]

Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs

UPPSALA, Sweden -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology. The Olink platform represents the cutting edge in proteomics technology, delivering exceptional sensitivity and specificity for protein biomarker [...]

Psomagen Puts Spatial Biology and Multiomics in Focus, first CRO to launch 10X Genomics Xenium™ in situ Analyzer services in North America

ROCKVILLE, Md. -- Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community's access to spatial genomics. According to Psomagen [...]

Access IBO on Knowledge Center